Abstract
connected to the HD machine, but had no contact with the The aim of this study was to evaluate the effects of blood of the patient. It recorded the urea concentration in treatment time on removal of small and intermediate the dialysate outflow as well as enabling representative size solutes during a single dialysis session as well as sampling of dialysate. The urea monitor allows for determinain the 24-h post-dialytic period.
tions of the removed amount of urea with high precision and based on these values Kt/V (according to Daugirdas II ) and urea removal rate ( URR) are continuously calculated
Subjects and methods
and presented on a screen during the dialysis.
In parallel with measurements by the urea monitor, urea Subjects concentrations in plasma were analysed by an enzymatic colorimetric test using double samples. This was done at the Ten patients, five women and five men (age 61±6 years, department of Clinical Chemistry at this hospital. body weight 68±4 kg) with end-stage renal disease and maintenance HD three times a week participated in the Iohexol measurements study. It was approved by the ethical committee of the University of Gö teborg. All patients were recruited from the Iohexol is a non-ionic, low-osmolar, X-ray contrast medium Sahlgrenska University Hospital and they gave their written with a molecular weight of 821 Daltons and it is mainly informed consent before entering the study. Only patients eliminated from plasma in its intact form by glomerular who were regarded to be in a stable clinical condition, with filtration (extrarenal clearance #2 ml/min) and it is often respect to their underlying renal disease, standard laboratory stated to be effectively removed by HD [7, 8] . Iohexol variables and blood pressure were selected for the study. (300 mg/ml, 10 ml, OmnipaqueB, Nycomed) was adminisThree patients had no residual renal function (RRF ) whereas tered approximately 44 h before each study session. During the RRF of the other seven patients ranged between 0.1 and this time it is effectively equilibrated in the extracellular fluid 1.4 ml/min/ 1.73 m2, which was corrected for in the sub-volume (ECV ) and can serve as a marker of this compartsequent calculations by assuming free filtration of iohexol. ment [7] . Iohexol concentrations in plasma, dialysate and The RRF was obtained in the generally used way, urine were determined by high-performance liquid chromatothat is from the average of the determination of urea and graphy (HPLC ). The intra-assay coefficient of variance creatinine clearance (Cl ) in each patient, i.e. RRF= was 5.12%.
The iohexol analysis performed by HPLC technique is The vascular access was achieved through AV fistulae in advantageous, since it requires only small volumes of plasma. seven and through central venous double-lumen catheters in three patients. Except for the treatment time variable the Calculations dialysis sessions followed the routine dialysis regimes using standard dialysis monitors and low-flux cellulose membrane Kt/V values were calculated in the following ways: dialysers (AK 100 and GFS 20 respectively, Gambro, (i) Kt/V for urea in blood was calculated according to the Sweden).
Daugirdas II formula [5] , (eq. 1)
Methods
where K is clearance (ml/min), t is treatment time (min), V
Experimental protocol
denotes the volume of distribution ( l ), C the concentration of solute (mg/ml ) at time t and at start 0, Uf the ultrafiltration The study period was 2 weeks. The ordinary dialysis schedule (ml/min) and W the body weight (kg). was followed with the exception of the midweek dialysis
The Kt/V values for urea provided by the urea on-line session. The first week the midweek dialysis had a 3-h monitor are based on the same expression (eq. 1). duration and the following week 6 h. During the short (3-h) (ii) For determinations of blood Kt/V of iohexol a slightly dialysis treatment session the blood flow was kept as high as modified version of the Daugirdas II formula was applied, possible in this patient group (250-300 ml/min). Based on where the generation term was omitted: the calculated urea Kt/V value (Daugirdas II [5] ) obtained from this session, the blood flow was adjusted to reach a Kt/V=−LN
) similar urea Kt/V for the 6-h treatment (approximately 100 ml/min).
(iii) Estimates of Kt/V can also be based on the removed Blood samples for analyses of urea and iohexol were mass, where K is obtained from: repeatedly collected, immediately before the start of dialysis, during the treatment, and in the first post-dialytic hour. All together 10 samples were collected from each session. K= m
(3) Moreover, the plasma concentrations of urea and iohexol were determined after 24 h. All samples were collected by venepuncture in the contralateral arm to the vascular access Moreover, V equals total body water for urea and creatinin order to avoid influences of recirculation.
ine and the extracellular volume for iohexol. The formulas of Watson et al. [9] were applied for determinations of V and the extracellular fluid volume was assumed to constitute
Urea measurements
one-third of V. The predialysis oedema removed by ultrafiltration was assumed to be distributed mainly in the extraAn on-line urea monitor for repetitive measurements of dialysate urea concentrations was used during the study cellular compartment.
Dialysate volume and removed mass. The total volume of sessions ( Urea monitor, Gambro, Sweden). This device was Table 1 . Removed mass of urea and iohexol after 3-and 6-h (HD) dialysate (V t ) used during each HD session was provided by treatment respectively (mean±SE). The urea values were obtained the product of dialysate flow rate recorded by the urea by the on-line urea dialysate monitor, while the removed mass of monitor (500 ml/min±1%) and time. A precise sampling of iohexol was calculated using mass balance. Moreover, mass balance analysis is simplified for iohexol of iohexol since there is no generation in the body. Thus, the iohexol (mg) mass prior to dialysis equals the sum of that removed by HD (m HD ), the amount remaining at 24 h and the iohexol excreted in the urine:
Where C p denotes the plasma concentration at time t or the average plasma concentration, V i,t denotes the extracellular volume at time t, RRF denotes the residual renal function and m HD is the mass removed by dialysis. Possible extrarenal elimination was not included in this equation.
Statistical methods
Results are presented as means±SE. Statistical significance of differences was tested with Student's two-tailed t-test for paired data. Differences with a P value<0.05 were considered as statistically significant.
Results
The first 3-h HD session was performed with an average blood flow of 293±5.3 ml/min and the second 6-h HD with an average blood flow of 118±2.0 ml/min. No adverse events occurred during or between the HD sessions.
Effects of treatment time on clearance and removed mass of urea and iohexol

Urea
The blood urea Kt/V (Daugirdas II formula) was similar for the 3-and the 6-h HD, reaching 0.87±0.06 and 0.92±0.07 respectively (n.s). The corresponding Table 1 ). Also the Kt/V based on calcu-was significantly higher after 6 h HD compared to 3 h (P<0.01), lations of removed mass were slightly higher compared despite similar blood Kt/V for urea for the two treatment regimens. to the blood Kt/V urea values, and differed significantly between the two treatment times: 0.95±0.04 for the Iohexol short and 1.03±0.04 for the longer HD (P<0.05). The removed mass of urea based on dialysate concen-Kt/V for iohexol based on the analysis of blood samples was significantly lower for the 3-h HD, 1.18±0.10, tration analyses were more variable and the differences did not reach statistical significance, see Table 1 and compared to 1.51±0.15, for the 6-h HD (P<0.05).
Also the removed mass of iohexol calculated using Figure 1a . Figure 1b) . partments during dialysis. Attempts to correct for the effects of treatment time using equilibrated (e)Kt/V Post-dialytic concentrations of iohexol and urea [10] did indeed reveal a significant difference, eKt/V being 0.92±0.07 and 1.20±0.12 for 3 h and 6 h of HD respectively (P<0.01). A similar pattern was The blood concentration of iohexol increased after HD observed with the Kt/V data obtained using equation without any generation or additional injections 3, see Results. ( Table 2) . Thus, the 'apparent' mass of iohexol came
The post-dialytic increase of the 'apparent' mass of down to 29±2.2% and 21±3.0% of predialysis values iohexol was significantly higher after the shorter diaafter 3-and 6-h HD respectively (P<0.05) After 24 h lysis session, while no such effects were observed for the iohexol level was 46±4.0% for the 3-h HD and urea. Moreover, the rebound is far greater for iohexol 36±3.5% for 6-h HD compared to predialytic levels than generally appreciated from urea kinetics. Since (P<0.05, Figure 2) .
there is no endogenous generation of iohexol, the There was no significant difference in post-dialytic continuous increase of the post-dialytic plasma iohexol concentrations of urea between 3-and 6-h HD, either concentration is interpreted as a rebound effect attribimmediately after the dialysis or during the subsequent utable to variations in blood flow distribution between 24 h ( Table 2) . body compartments.
The initial protocol of this study included determinations of Kt/V for urea and iohexol based on blood Discussion samples and analyses of removed mass of solutes in the dialysate. However, the low concentrations of The results of the present study demonstrate that the iohexol in the dialysate were influenced by background duration of the HD session per se affects the removal activity. The interpretation of the dialysate concentraof solutes. Hence, the Kt/V-values based on the tions therefore became somewhat ambiguous and the removed mass of urea and iohexol were significantly data presented in Table 1 were obtained from mass balance analysis from the plasma concentrations of itatively similar to those obtained by analysis of the dialysate but those measurements had a higher variability. This was also the case for urea where the removed mass determined from the dialysate urea monitor showed considerable variation and did not reach statistical significance see Table 1 . In contrast, the Kt/V values for urea determined by the urea monitor were significantly higher for the longer dialysis, see Results.
The Kt/V values obtained from calculations of removed mass of urea as well as by the on-line urea monitor were higher than the corresponding blood Kt/Vs. This could be explained by consequences of compartment disequilibrium induced by the dialysis. In order to avoid influence of recirculation the opposite arm to the vascular access site was used for venepuncture and for collection of blood samples. However, this precaution was probably counteracted by the fact that this opposite arm instead can behave as a compartment with high resistance to urea diffusion [11] . This 
Kt/V concept based on urea kinetic modelling has remained a key variable for the assessment of the dose To compensate for the reduced dialysis treatment times with increased blood flows may accentuate the of dialysis [17] . Nevertheless, the Kt/V must be interpreted with caution, since the estimated Kt/V tends to impact of the uneven blood flow distribution. Thus, for a given Kt/V a decreased dialysis duration implies overestimate the delivered dialysis dose. The various models that compensate for uneven flow-distributions an increased ultrafiltration rate resulting in a relative hypovolaemia in the cardiopulmonary region. As a to different organs provide better reflections of urea removal and rebound after HD than the singleconsequence volume-and baroreceptors may be activated and increase the sympathetic vasoconstrictor compartment model [18, 19] . The results of the present study further stress that a reduced duration of the HD activity, mainly to the skeletal muscles. The total peripheral resistance will subsequently increase and session must be compensated for by a relatively higher Kt/V in order to reach the same delivered dose of urea removal from that compartment may be reduced in parallel to the altered blood flow distribution [12] . dialysis in terms of solute removal [4] . Moreover, this effect of time seems to be pronounced for intermediateThe design of the study implies that each patient serves as its own control, participating in two HD size molecules. It is plausible that it therefore should be significant for the uraemic toxins in this size range. sessions for 3-and 6-h duration respectively. Kt/V for urea was calculated for the 3-h HD, with blood flows An alternative way to quantify dialytic therapy is to measure the actual removed mass of solutes. This is kept as high as the vascular access allowed. The flow of the subsequent 6-h HD was adjusted with the now possible by the urea monitoring sensors. For clinical practice, urea monitoring is simple, practical purpose to reach a similar Kt/V value. In this patient population it was, however, not possible to reach and reliable. The urea monitor used in the present study represents a 'second generation' with very a high higher blood flows than 250-300 ml/min. The magnitude of urea rebound shortly after dialysis has previ-precision [20] . The device is connected to the dialysate outflow of the HD machine, which facilitates repetitive ously been correlated to the efficiency of the dialysis expressed as urea removal [13] or urea Kt/V [6 ] where analyses of the removed mass of urea without interference with the patient. These recordings make it possible the dialysis dose was altered by varying the blood flow. If anything, the effects of treatment time per se reported to present 'on-line' Kt/V values. In addition, the present urea monitor allows for representative dialysate samin the present investigation would be even more pronounced with higher blood flows.
pling which makes it possible to determine the content of other solutes than urea, for instance of iohexol. A complementary approach to kinetic analyses is to determine the clearance of exogenous markers like In summary, the results of this study suggest that longer dialysis treatment times may provide beneficial iohexol. Such intermediate-size molecules should exclusively be extracellularly distributed and thereby effects since intermediate sized solutes are more effectively removed despite the same blood Kt/V for urea. serve as a marker of the extracellular compartment [7] . Other factors that influence the kinetic estimates are minimized, since there is no endogenous production Acknowledgements. prolonged process than the generally appreciated 1-2 h [6 ] . Alternative explanations to the post-dialytic increase of the iohexol concentration could include an
